PEDro scale
| Author | I | II | III | IV | V | VI | VII | VIII | IX | X | XI | Total score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baldon et al44 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 10 |
| Nakagawa et al40 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
| Ismail et al39 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 8 |
| Fukuda et al23 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
| Fukuda et al38 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
| Ferber et al42 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 7 |
| Khayambashi et al43 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
| Razeghi et al37 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Dolak et al24 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 6 |
| Ferber et al46 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| Khayambashi et al26 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| Avraham et al41 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 4 |
| Tyler et al45 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 3 |
| Earl and Hoch25 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 3 |
I=Eligibility criteria specified, II=Random allocation, III=Concealed allocation, IV=Similar at baseline, V=Subject blinding, VI=Therapist blinding, VII=Assessor blinding, VIII=Outcome measures obtained from >85%, IX=Treatment received as allocated, X=Between-group statistical comparison, XI=Point measures and measures of variability.